Being Social: The FDA Pronounces on Interactive Promotional Media
Marianne Slivkova, Senior Corporate Counsel, Bristol Myers Squibb, USA
In the United States, consumers are increasingly turning to social media to obtain information about pharmaceutical products and devices, to research medical conditions, and obtain information about potential treatments, available support groups and other health-related information.
Data from Manhattan Research (for the year 2013) indicates that social media influences the patient journey in unprecedented ways: for example, upwards of 20% of consumers surveyed were “strongly influenced” by social media when experiencing symptoms, after diagnosis, or when managing their condition. Social media has also influenced patients’ interactions with their doctors: 27% of consumers using social media reported that they asked a doctor to prescribe a generic instead of a brand as a result of health/medial information they found on-line, 12% asked a doctor to prescribe a brand, and 25% asked a doctor to prescribe any drug.
Read full paper
Subscribe to the IICJ